Sucampo Pharmaceuticals (NASDAQ:SCMP) announced that earnings increased to $13.5 million, or 32 cents per share, up from $2.7 million, or 6 cents per share. Revenue increased to $34.9 million from $14.2 million, while research and development revenue increased to $15.2 million from $2.7 million, and royalty payments increased from $10.8 million to $14.2 million. Product sales increased to $5 million versus none in the same period last year.
Christopher & Banks (NYSE:CBK) announced that it lost $4.1 million, or 11 cents per share during the fiscal fourth quarter, versus a loss of $53.2 million, or $1.50 per share, in the same period last year. Revenue increased by ten percent to $116 million from $105.6 million, while same store sales increased by 18.5 percent.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.